Literature DB >> 20676855

Predictors of postoperative survival in patients with locally advanced non-small cell lung carcinoma.

Akira Iyoda1, Kenzo Hiroshima, Yasumitsu Moriya, Shigetoshi Yoshida, Makoto Suzuki, Kiyoshi Shibuya, Ichiro Yoshino.   

Abstract

PURPOSE: A surgical resection for locally advanced non-small cell lung carcinoma (NSCLC) remains controversial. This study analyzed the clinicopathological profile and surgical outcome of patients with locally advanced NSCLC to identify the predictors of survival.
METHODS: This study retrospectively analyzed clinical data from 86 patients with pathological T3 or T4 primary NSCLC treated at Chiba University Hospital, and evaluated prognostic factors.
RESULTS: Sixty-eight of 86 cases were treated with a complete resection, and 18 were evaluated as an incomplete resection. The 5-year overall survival rate of all cases was 45.7%. Univariate analyses of survival were performed to determine the predictors of overall survival in patients with pathological T3 or T4 NSCLC. Age of 70 years or more, tumor length more than 5 cm, lymph node metastases, incomplete resection, and histology of non-adenocarcinoma were significantly associated with an unfavorable prognosis. Multivariate analyses revealed that older age, incomplete resection, and lymph node metastases were independent predictors of shorter survival.
CONCLUSION: A complete resection for selected cases is acceptable in the management of T3 or T4 NSCLC.

Entities:  

Mesh:

Year:  2010        PMID: 20676855     DOI: 10.1007/s00595-009-4127-1

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  12 in total

1.  Surgical treatment of lung cancer invading the chest wall: results and prognostic factors.

Authors:  P Magdeleinat; M Alifano; C Benbrahem; L Spaggiari; C Porrello; P Puyo; P Levasseur; J F Regnard
Journal:  Ann Thorac Surg       Date:  2001-04       Impact factor: 4.330

2.  Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience.

Authors:  T Naruke; R Tsuchiya; H Kondo; H Asamura
Journal:  Ann Thorac Surg       Date:  2001-06       Impact factor: 4.330

3.  Lung cancer invading the chest wall: a plea for en-bloc resection but the need for new treatment strategies.

Authors:  Christophe Doddoli; Benoit D'Journo; Françoise Le Pimpec-Barthes; Antoine Dujon; Christophe Foucault; Pascal Thomas; Marc Riquet
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

4.  Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term results.

Authors:  G Stamatis; W Eberhardt; G Stüben; S Bildat; O Dahler; L Hillejan
Journal:  Ann Thorac Surg       Date:  1999-10       Impact factor: 4.330

5.  Results of en bloc resection for bronchogenic carcinoma with chest wall invasion.

Authors:  Harold M Burkhart; Mark S Allen; Francis C Nichols; Claude Deschamps; Daniel L Miller; Victor F Trastek; Peter C Pairolero
Journal:  J Thorac Cardiovasc Surg       Date:  2002-04       Impact factor: 5.209

6.  Extent of chest wall invasion and survival in patients with lung cancer.

Authors:  R J Downey; N Martini; V W Rusch; M S Bains; R J Korst; R J Ginsberg
Journal:  Ann Thorac Surg       Date:  1999-07       Impact factor: 4.330

7.  Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer.

Authors:  D H Grunenwald; F André; C Le Péchoux; P Girard; C Lamer; A Laplanche; M Tarayre; R Arriagada; T Le Chevalier
Journal:  J Thorac Cardiovasc Surg       Date:  2001-10       Impact factor: 5.209

8.  Characteristics and prognosis of resected T3 non-small cell lung cancer.

Authors:  Marc Riquet; Loïc Lang-Lazdunski; Pimpec-Barthes Françoise Le; Antoine Dujon; Redha Souilamas; Claire Danel; Dominique Manac'h
Journal:  Ann Thorac Surg       Date:  2002-01       Impact factor: 4.330

9.  Induction chemoradiotherapy and surgical resection for selected stage IIIB non-small-cell lung cancer.

Authors:  Yukito Ichinose; Yasuro Fukuyama; Hiroshi Asoh; Chie Ushijima; Tatsuro Okamoto; Jiro Ikeda; Junichi Okamoto; Maki Sakai
Journal:  Ann Thorac Surg       Date:  2003-12       Impact factor: 4.330

10.  Survival and prognostic factors of surgically resected T4 non-small cell lung cancer.

Authors:  Toshihiro Osaki; Kenji Sugio; Takeshi Hanagiri; Mitsuhiro Takenoyama; Toshihiro Yamashita; Masakazu Sugaya; Manabu Yasuda; Kosei Yasumoto
Journal:  Ann Thorac Surg       Date:  2003-06       Impact factor: 4.330

View more
  5 in total

1.  [Long-term survival of personalized surgical treatment of locally advanced non-small cell lung cancer based on molecular staging].

Authors:  Qinghua Zhou; Yingkang Shi; Jun Chen; Bin Liu; Yun Wang; Daxing Zhu; Hong-Tao Zhang; Peng Xu; Youling Gong; Gang Chen; Sen Wei; Xiaoming Qiu; Zhongxi Niu; Xiaofeng Chen; Zhe Lei; Liang Duan; Zhu Wu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-02

2.  mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry.

Authors:  Liang Wang; Wentao Yue; Lina Zhang; Xiaoting Zhao; Yue Wang; Shaofa Xu
Journal:  Surg Today       Date:  2011-11-30       Impact factor: 2.549

3.  The influence of intracellular epidermal growth factor receptor (EGFR) signal activation on the outcome of EGFR tyrosine kinase inhibitor treatment for pulmonary adenocarcinoma.

Authors:  Daigo Kawano; Tokujiro Yano; Fumihiro Shoji; Kensaku Ito; Yosuke Morodomi; Akira Haro; Naoko Miura; Tomoyoshi Takenaka; Ichiro Yoshino; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-05-28       Impact factor: 2.549

4.  Relationship between EGFR gene mutation and local metastasis of resectable lung adenocarcinoma.

Authors:  Yunqiang Nie; Wei Gao; Na Li; Wenjun Chen; Hui Wang; Cuiyun Li; Haiyan Zhang; Ping Han; Yingmei Zhang; Xin Lv; Xinyi Xu; Hongyan Liu
Journal:  World J Surg Oncol       Date:  2017-03-03       Impact factor: 2.754

5.  Prognostic factors in operated T3 non-small cell lung cancer: A retrospective, single-center study of 129 patients.

Authors:  Ahmet Uluşan; Maruf Şanlı; Ahmet Feridun Işık; Miray Ersöz; Bülent Tunçözgür; Kemal Bakır; Seval Kul; Levent Elbeyli
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-01-09       Impact factor: 0.332

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.